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Abstract 
How can EU policies support the development of innovation capabilities in less developed regions? 
This note examines the mobilisation of the EU’s two major innovation support instruments: the 
European Structural and Investment Funds (ESIF) and Horizon 2020 (H2020). Using data from 
Eurostat and European Commission administrative data on ESIF and H2020 funding, we observe a 
number of salient patterns. While newer member states benefit from higher research and innovation 
allocations from ESIF, participation in H2020 remains a formidable challenge. Across Europe we find 
that H2020 participation is closely associated with a number of proxies of the development of 
national and regional innovation systems. With few exceptions (most notably Slovenia and the Czech 
Republic) newer member states are characterised by lower overall R&D intensity, their research and 
innovation systems are less internationalised and most R&D is performed by public research 
institutions rather than businesses. Based on a review of literature on the determinants of 
participation in the H2020 (and its predecessor Framework Programmes), the history of today's 
advanced innovation systems and a consideration of the objectives of, modes of intervention of and 
possible complementarities between ESIF and H2020 we single out international collaboration and 
business innovation capabilities as important instrumental objectives for development-minded 
policy. 
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Executive Summary 
How can EU policies support the development of innovation capabilities in less developed regions? 
This note examines the mobilisation of the EU’s two major innovation support instruments: the 
European Structural and Investment Funds (ESIF) and Horizon 2020 (H2020). ESIF – with its focus on 
productivity and income convergence and attendant support to broad-based innovation investments 
- is more relevant to regions with low innovation capabilities whereas H2020 – with its focus on 
precompetitive research of global significance – becomes progressively more relevant to regions with 
higher innovation capabilities. In principle, both ESIF and H2020 are open to all regions. However, 
take-up of ESIF for innovation and participation in H2020 are very unequally distributed across 
regions with similar capability deficits. Unequal distribution is not merely confined to partly 
inevitable territorial disparities within countries but, importantly, is also evident across national 
borders. Regions in Central and Eastern Europe - largely new member states - and also Southern 
Europe appear to be particularly affected. 
Participation in H2020 is often singled out as a particularly pressing problem in less developed 
regions. In addition to much-needed resources from its sizeable budget, H2020 provides unparalleled 
opportunities to participants from less developed regions to engage with international scientific and 
technological networks and address research questions of global economic significance. To 
understand possible reasons for low participation, we review literature on the determinants of 
success in H2020 and predecessor Framework Programmes for Research and Technological 
Development (FP).  We find that prior participation in the FP, networks and collaboration, 
organisational characteristics, and importantly, national system and funding structures all combine to 
construct the scientific excellence that the FP/H2020 is known to select for. Additionally, FP/H2020 
participation may reflect self-selection, whereby either very weak participants, or very strong ones, 
who can tap on alternative funding sources, choose not to participate. H2020 presupposes a 
minimum level of research and innovation capability necessary to engage with global research 
questions of economic significance. However, less developed regions are typically characterised by 
weak business innovation capabilities and by public research institutions and tertiary and vocational 
education that struggle to keep up with the demands of international science or globalised industry.  
We recall the policy objectives of ESIF and H2020 and examine their potential impacts in terms of 
regional innovation capability accumulation. Taking cues from the economic history of advanced 
innovation systems, we highlight the central role of business innovation capabilities in the long-run 
development of thriving innovation systems. ESIF can help prop up capabilities in less developed 
regions with weak innovation systems until such time as they can participate more fully in H2020. In 
support of this goal ESIF innovation investments can be focused on two specific instrumental 
objectives: to support the internationalisation of public research on the one hand, and to support the 
development of business innovation capabilities on the other. 
As discussed elsewhere (e.g. see European Commission, 2014) mobilising ESIF for innovation is 
largely down to administrative capacities to orient, coordinate, programme and implement 
innovation projects. RIS3 provides a new framework for this kind of mobilisation to happen. 
However, even with RIS3 and the mobilisation of sizeable ESIF resources for innovation, 
accumulation of the necessary innovation capability within both the business sector and the wider 
innovation system takes time and is not guaranteed. The risk of insufficiently tailored policy mixes is 
well recognised but not always addressed. This may materialise, for instance, with too little support 
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for broad-based innovation, including non-R&D innovation activities in design, marketing, 
engineering, training, information technology and management that are important for new-to-the-
firm and new-to-the-industry innovation, and which, on the long run, can be a stepstone to and 
complementary to R&D. Poor tailoring may manifest in insufficient attention to the types (e.g. 
organisational and marketing versus technological innovation) and modes of innovation (e.g. in-
house broad-based innovation activities versus collaborative research) that are most relevant to 
businesses in the region.  
We explore some potential complementarities between ESIF and H2020 at the level of policies. At 
least conceptually, the ways in which the two instruments impact on capability accumulation can 
overlap and reinforce one another. In developing systems that are of primary interest to cohesion 
policy, the two instruments complement each other in a stepwise manner, with ESIF investments 
helping build the scientific excellence required to further benefit from H2020. However, a range of 
obstacles can stand in the way of harnessing complementarities. At the level of policies (as distinct 
from projects), these can include the absence of long-term planning horizons, the absence of the 
necessary governance infrastructure and reforms required and the lack of suitable policies for 
capability development that are in keeping with stage of the innovation system’s development.  
A key issue appears to be that administrative rules and procedures for ESIF and H2020 are not always 
compatible. Rules may also require adaptation to the economic and institutional realities of newer 
member states. Other important barriers include the absence of national sources of funding to pick 
up those parts of the innovation value chain not supported by EU funds and, crucially, the absence of 
a critical mass of R&D-performing businesses, which appear to be important in steering public 
research and skills provision and are in any case necessary if H2020 participation is to have local 
economic impact. Along with opportunities to harness complementarities, possible and anecdotally 
reported undesirable outcomes deserving further study are identified such as long-term dependence 
on funding from European sources and substitution between ESIF and H2020.  
We then examine some salient structural features of EU innovation systems, drawing from statistical 
information on R&D expenditures (most notably the shares of public and business innovation within 
the national aggregate) and administrative information regarding participation in ESIF and H2020 at 
the national and regional level. With few exceptions (most notably Slovenia and the Czech Republic) 
newer member states are characterised by lower overall R&D intensity. Most R&D is performed by 
public research institutions rather than businesses, and ESIF research and innovation allocations 
account for a larger share of GDP (around 0.4% for Poland, Slovakia, Lithuania and Latvia and as 
much as 0.6% for Estonia). In contrast, with some exceptions (most notably Slovenia and Estonia), 
the countries where H2020 funding accounts for a greater share of GDP, tend to be older member 
states, with higher overall R&D intensities, and in which businesses perform most R&D. Newer 
member states appear to be less well integrated into international scientific networks, as suggested 
by the overall lower shares of international co-publications. At the national level, and among the 
variables considered, international co-publications, followed by business R&D intensity are the 
variables most closely associated with H2020 participation.   
The regional picture is more nuanced. Among the 20 member states for which our data permit us to 
examine sub-national variance (usually at the NUTS2 level) we observe greater within-country 
differences in regional allocation of funding (defined as the percentile difference between the region 
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with the national minimum and the region with the national maximum) for H2020 than for ESIF. 
Greece, followed by Spain, Belgium and Italy are the countries with the greatest intra-national 
regional differences in H2020. Poland, Portugal and Hungary are the countries with the greatest 
intra-national regional differences in ESIF funds. Finally, capital regions tend to attract more H2020 
funding, which underscores the importance of co-location for innovation activity of this kind.  
We finally identify some salient characteristics of regions that stand to benefit from greater 
participation in H2020. We examine 200 EU regions for which data are available in terms of their 
participation in ESIF, H2020 and their R&D intensity, the latter being an important indicator of overall 
innovation capability. As a result of this analysis we divide all EU regions into three groups: lagging, 
transition and better-performing regions. “Lagging regions” are regions with low R&D intensity (less 
than 1 per cent of GDP) and a ratio of H2020 to ESIF funding below 1. They tend to be concentrated 
in newer member states and also in Southern Europe. “Intermediary regions” comprises of regions 
with a notable R&D intensity (at least 1 per cent of GDP) and a ratio of H2020 to ESIF funding below 
1. Intermediary regions could be of particular interest to policy, as their participation in H2020 is 
below that expected from their overall R&D intensity, and may be where the largest policy gains can 
be had at short order. “Better-performing regions” exhibit both a notable share of R&D and a high 
(greater than 1) ratio of H2020 to ESIF funding. Lagging and Transition regions will inevitably have to 
ensure that ESIF funding is channelled in support of innovation capability accumulation. Support for 
both the internationalisation of public research and the development of business innovation 
capabilities seem relevant to most regions in these groups and offer fruitful directions for future 
European policy. However, the precise targets for policy attention are likely to differ between 
countries and regions and will require context-specific analysis. 
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1 Introduction 
Innovation policy is central to tackling the multifaceted challenges facing Europe’s regions, among 
others: sluggish economic growth, globalisation, demographic changes and climate change.  Regions 
with incomes per capita below the EU average or with sluggish economic growth in particular, are 
finding it difficult to benefit from either national and EU innovation policy frameworks and 
instruments. Territorially differentiated, inclusive, and appropriately sequenced responses 
supporting broad-based and progressively more ambitious innovation seem necessary. Research and 
Innovation Smart Specialisation Strategies (RIS3) provide a framework that facilitates long-term 
planning and resource mobilisation. 
The creation of synergies between the two main sources of EU funding dedicated to research and 
innovation - the European Structural and Investment Funds (ESIF) and Horizon 2020 (H2020) - is an 
important challenge in the implementation of RIS3. Harnessing synergies is a challenge in more ways 
than one. Until now the bulk of the discussion has been about synergies at the level of projects – that 
is, combining different instruments to ensure that scale and scope economies are achieved 
(European Commission, 2014)1. However, synergies at level of policies - and of appropriate 
adaptations to the national and regional policy mix in particular - have not been investigated. As we 
discuss in this report, synergies at the level of policies imply territorial tailoring of instruments, 
sequencing between them, and their meaningful embedding into long-term RIS3 processes. 
This report provides an overview of mobilisation of ESIF and H2020 at the regional level and 
examines some of its aggregate patterns. Specifically, we examine mobilisation experience against 
the following questions: 
 What are the possible complementarities, at the level of policies rather than projects, 
between ESIF and H2020? 
 What are the main structural features of EU innovation systems at the national and regional 
levels and how do they shape the mobilisation of ESIF and H2020 funds? 
 What are the roles of EU, national and regional policies in bringing about meaningful change 
in the innovation systems of regions with different capability deficits?   
The overarching objective is to articulate possible directions2 for policies that strengthen innovation 
capabilities and outcomes in the less developed regions of Europe. To this end we investigate in 
particular how ESIF and H2020 can be used in a mutually reinforcing fashion and identify 
instrumental policy objectives. The report is structured as follows.  
As H2020 participation is identified as a particularly pressing problem in less developed regions, we 
begin with a brief review of the determinants of participation in the FP, showing that prior 
                                           
1 This discussion elsewhere focuses on complementarities (or synergies) in the narrow sense of combining 
funding from various instruments to maximise the overall amount devoted to a particular project, theme or 
priority (or support different parts of). However, unexploited scale economies are not always a problem, 
and may not be the key bottleneck preventing capability accumulation and development. For this reason 
we consider here complementarities at the level of the policy mix, which is combining specialised 
instruments and their various support mechanisms to achieve long-term, aggregate policy objectives, such 
as to build business innovation capabilities, to foster scientific excellence and internationalisation, 
university-industry interaction etc. This perspective brings issues related to sequencing and to focusing 
resources to binding constraints for aggregate development to the fore. 
2 This overview would also help inform two EC initiatives co-implemented by DG REGIO and JRC, namely:  S2E 
and RIS3 Support to Lagging Regions, to better define their future activities. 
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participation in the FP, networks and collaboration, organisational characteristics, and importantly, 
national system and funding structures all combine to construct the scientific-excellence that the FP 
is known to select for. Additionally, FP participation may reflect self-selection, whereby either very 
weak participants, or very strong ones, who can tap on alternative funding sources, choose not to 
participate. We provide an overview of the rationales for synergies between ESIF and H2020 at the 
level of policies and consider how ESIF can support the development of scientific excellence, and, 
importantly, innovation capabilities more generally, particularly in the business sector. We argue that 
business innovation capabilities are of central importance in the long-term development of regional 
innovation systems and deserve closer attention. 
Drawing from administrative data on pre-allocated and place-based ESIF and spatially-blind and 
competitive H2020 funding, we show the extent of mobilisation across EU member states and their 
within-country variation. We observe that funding mobilisation in each instrument is broadly shaped 
by structural features of national research and innovation systems, such as the presence of capital or 
metropolitan regions, international cooperation and the share of business R&D funding and 
performance. 
Finally, we show that the relative mobilisation of ESIF and H2020 across 200 European regions is 
closely associated with their R&D intensity, which we take as a proxy of the overall development of 
their innovation system. We then classify each region and provide some initial thoughts on the kinds 
of policies what would be most appropriate in each type. 
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2 What determines H2020 funding mobilisation? A review of the 
literature 
Take-up of ESIF for innovation and participation in H2020 are distributed very unequally across 
regions with similar capability deficits. Unequal distribution is not merely confined to partly 
inevitable territorial disparities within countries but, importantly, is also evident across national 
borders. Regions in Central and Eastern Europe - largely new member states - and also Southern 
Europe appear to be particularly affected. Whereas, mobilising ESIF for innovation is largely down to 
administrative capacities to orient, coordinate, programme and implement innovation projects 
(European Commission, 2014; Gianelle et al., 2016; Boden et al., 2016), success in the FP is a 
multifaceted challenge. 
Participation in H2020 is often singled out as a particularly pressing problem in less developed 
regions. Given the disparities in scientific and technological capabilities between EU member states, 
the take up of Framework Programme funding in the EU is skewed towards member states that 
joined the EU before 2004 (Annerberg et al, 2010; European Commission, 2017). This is especially 
problematic from a development perspective, as in addition to much-needed resources from its 
sizeable budget, H2020 provides unparalleled opportunities to participants from less developed 
regions to engage with international scientific and technological networks and address research 
questions of global significance.  
A number of studies have shown success in the FP is overwhelmingly determined by participant 
attributes that can be good proxies of scientific excellence – such as the number of publications and 
the average number of citations (Geuna, 1998; Henriques et al., 2009). However, scientific 
excellence, both in its construction where it previously did not exist and in its visible manifestations 
such as high-impact publications, is both an economic and a social process. Learning and improved 
human capital are natural outcomes of sustained international collaboration. But familiarity among 
research teams who have previously worked together, manifesting in lower coordination costs, may 
also result in biases. The award of research funding is not always a natural process by which the best 
researchers cumulate advantages based on the quality of their ideas (Viner et al., 2004). Rather, it 
can be a cumulative-causation process, whereby initial success becomes a self-perpetuating 
phenomenon, rather than one invigorated by competition.  
Prior participation in the Framework Programme 
The so-called "Matthew effect" in science refers to the phenomenon of research groups that have 
been successful in obtaining external funding having a greater chance of producing publishable 
research that in turn improves the chance of getting further funds in the future (Geuna, 1996). More 
specifically, it has been argued that overall research output has an effect on participation in FP 
(Ukrainski, 2014). Furthermore, an important factor in relation to the successful application for 
external funding is whether there have been collaborative relationships prior to the award of funding 
(Defazio et al., 2009). Along with the low level of FP participation it can be demonstrated that less 
developed regions have a low level of overall international co-publication intensity (Harrap and 
Doussineau, 2017). This implies good prior performance is an advantage in obtaining funding as such 
an institution is seen as less risky than one that has never been funded (Geuna, 1996).  
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Such success due to prior participation means that the universities and research institutes with high 
reputations become more connected and central to a network through repeated participation in EU 
Framework Programmes (FPs) (Protogerou et al., 2010). Such selection mechanisms mean that early 
entrants have advantages in terms of repeated participations (Geuna, 1998; Heller-Schuh et al., 
2011), as they achieve a more central position in the FP networks that confer further advantages in 
terms of FP participation. It follows that the lack of prior participation puts institutions from the EU13 
at a disadvantage. The role of prior participation is also evident with regards to business participation 
in the FP. A recent study for the European Commission (Open Evidence and Ernst and Young, 2016) 
found that lack of necessary skills and networks is a major barrier to business participation in the FP, 
particularly in new member states. 
Pre-existing research networks and collaboration structures 
Participation in FPs is concentrated in a highly clustered small group of institutions with high 
reputations (Lepori et al., 2015). While such small world networks are efficient for the transmission 
of knowledge, it can be difficult for new entrants to join and are therefore less effective for fostering 
integration (Heller-Schuh et al., 2011). A study of the area of information society technologies 
(Protogerou et al., 2010) suggests that the instruments of the FPs consolidate the position of 
incumbent core network actors while not allowing for promising peripheral organisations to assume 
more central roles.  
The choice of consortium partners for a FP proposal could have important consequences for project 
participation. To minimise cultural issues and geographic constraints, there can be a tendency to 
maintain well-known individual and team-level links (Okubo and Zitt, 2004). Makkonen and Mitze 
(2016) have shown that while there was an increase in co-publication intensities between old and 
new member states, following the latter's accession to the EU, the increase between new member 
states was more significant.  
Co-publication analysis also indicates that the new member states collaborate strongly together and 
this is replicated in FP participation, although some countries become less peripheral in their FP 
participation (Harrap and Doussineau, 2017). This indicates that the prior performance of a 
consortium influences the FP success of new members. This is also influenced by prior links in a 
researcher's wider international collaboration networks.  
FP networks show a stable core with a large number of projects with the same partners. Around this 
core there are some highly frequent participants as well as others that participate more rarely. These 
latter organisations will rarely join the core (Breschi and Malerba, 2009). It is further argued that 
research priorities and network organisation are defined by the core and that they demonstrate a 
tendency towards resistance to change. A counter argument is that the core co-regional pairs that 
co-publish frequently do not receive a disproportionate amount of funding from FP as it is distributed 
equally based on past scientific performance (Hoekman et al., 2013). This issue of performance and 
reputation is an important factor as it is a horizontal issue pertinent to the national system and 
characteristics of the organisation.   
National or regional R&I system characteristics  
One characteristic that appears particularly important is the degree of internationalisation in the 
national R&I system. A high degree of international openness, as reflected in international mobility, 
 13 
participation in transnational research teams and cross-border co-authorship, can have positive 
effects on the capacity of researchers to apply to international programmes such as the FP (Dinges 
and Lepori, 2006; Langfeldt et al., 2012).  
The relationship between internationalisation and the performance of the science system runs both 
ways. A recent study of the mobility of scientists shows that the attraction of a country is not 
systematically based on obtaining greater funding than their origin: High quality in the performance 
of a national science system is important and research excellence initiatives have an influence (Cuntz, 
2016). Furthermore, open science systems with more researchers coming in and going out produce 
higher impact research (Wagner and Jonkers, 2017). These are, collectively, strong indications of the 
interactive relationship between an internationally open system, research quality and attractiveness 
to researchers.  
While R&D intensity can indicate the regional presence of research-active organisations that can 
potentially participate in the FP, it is not just overall R&D intensity that matters but its composition 
too. As also shown in Section 4 of this report, countries with a higher share of R&D performed and 
funded by businesses typically perform better in the FP, in view of the instrument's focus on the pre-
competitive stage of research. For instance, a study of the extent of university-industry R&D 
collaboration in the FP by Azagra-Caro et al. (2013) found that much of the observed variance across 
European regions could be explained by the incidence of business R&D in the region. It is likely that it 
is not business R&D performance in the region per se that is important for FP participation, but what 
it signifies: sizeable business R&D investments are only possible when a constellation of problems in 
the innovation system have been effectively tackled, including the appropriate framework conditions 
for investment, the supply of adequate relevant skills and successful reform of public research so 
that it is synergetic and responsive to the demands of industry.  
Organisational characteristics 
International reputation has a strong influence on the extent of FP participation (Henriques, et al, 
2009; Lepori et al., 2015; Defazio et al., 2009). Prestigious institutions become better connected and 
more central in the network leading to repeat participation in the FP (Protogerou et al., 2010). The 
expectation that reputation improves the chances of a successful bid encourages applicants to act 
strategically in their selection of partners. This behaviour further fans the cumulative causation 
relationship between first-entry, high scientific research quality, high reputation and potential for 
repeat participation. The corollary is that newer participants have a higher chance of being left out. 
The lack of international reputation is an important barrier for new entrants to overcome. This is 
typically the case in new EU member states, where there are smaller numbers of world class 
institutions with the required reputation (Annerberg, et al., 2010).  
The size of the institution can also be a factor as large institutions may be better able to support and 
manage complex international collaboration projects (Geuna, 1996; Lepori et al., 2015). A common 
issue, anecdotally reported at S2E National Events,3 was the lack of expertise and experience in the 
proposal writing stage and the implementation of transnational collaborative projects (Özbolat and 
Harrap, forthcoming). Larger institutions, particularly those in older EU member states, may have 
greater resources to establish support mechanisms. 
                                           
3 Details on all 13 National Events including the Joint Statements issued by S2E and national authorities after 
the event can be found at: http://s3platform.jrc.ec.europa.eu/national-events  
 14 
A recent study by Enger and Castellacci (2016) considers the decision to actually submit a proposal; 
the stage during which some potential participants may opt not to participate (so-called self-
selection). Using a dataset comprising the entire population of research organisations in Norway, 
Enger and Castellacci (2016) find that, in addition to the importance of prior participation, access to 
national funding schemes that are complementary to the FP is an important determinant.  The 
challenge in the design of national funding schemes is to ensure that they complement and not 
substitute the FP, as  unconditional availability of more dependable national funds may also mean 
there is less need to apply to competitive and therefore uncertain funding streams such as H2020.  
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Productivity improvements / Economic growth and convergence 
 
3 ESIF and H2020: Policy objectives and potential complementarities 
from a development perspective 
Policy complementarities for development 
Enhancing the global competiveness of European industry on the one hand and supporting the 
convergence of productivity and income levels between European regions on the other, are the 
overarching economic objectives of EU research and innovation policies and EU regional 
development policies respectively (Guzzetti, 1995; Tondl, 1995; Chorafakis and Pontikakis, 2010). In 
keeping with these distinct objectives, historically the two sets of policies have followed their own 
development paths. This is evident in their main instruments:  
 the Framework Programme, known in its current iteration as the EUR 80 billion-plus 
“Horizon 2020” programme (H2020), which has spearheaded support for precompetitive 
research of global significance (chiefly in the form of centrally-administered and 
competitively-awarded funding for mainly collaborative research projects); and  
 the European Structural and Investment Funds (ESIF), which have supported productivity 
and income convergence across EU regions and countries by way of (targeted support for 
EU-funded but nationally-administered) investments.  
The recognition that the two objectives of competitiveness and cohesion can be mutually reinforcing 
is motivating an active search for overlaps and complementarities between the two sets of policies 
and their instruments. In principle, ESIF can be complementary to H2020 in several ways. In weaker 
innovation systems that are of primary interest to cohesion policy, the two instruments complement 
each other in a stepwise manner.   First, ESIF can support the initiation of innovation activities and 
accumulation of innovation capabilities, both in public research and education and in businesses. 
Then, as innovation capabilities accumulate in firms, and public research capacities are upgraded, 
weaker innovation systems progressively become better able to engage with H2020, access its 
networks and conduct research of global significance (see simplified diagram in Figure 1). In this 
stylised sequence, ESIF is much like the scaffolding meant to prop up a structure during its 
construction; and, although this is not always appreciated, just like the scaffolding, its gradual 
withdrawal is part of the plan. 
Figure 1: The role of ESIF and H2020 in regionally, nationally and globally significant 
innovation capability  
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Complementarities also exist because each of the two instruments can support the policy objectives 
of the other. H2020 obviously supports cohesion by linking research teams across European borders 
and facilitating learning. However, its main role in capability accumulation arguably comes by way of 
its ability to “raise the bar”. By supporting research questions of global significance, H2020 tends to 
raise the bar of quality and impact at that level (Henriques et al., 2009). Even before doing so 
directly, it can chart the way for the necessary reforms and steering of capabilities development that 
lead to convergence not just of capacities but also of outcomes. ESIF, courtesy of supporting less 
developed systems, is liable to support a wide range of sectors, technologies, firms and products. 
Other things being equal, over the long-run ESIF may contribute to the development of a more 
populous and, importantly, diverse pool of globally innovative European companies. These are just 
the obvious complementarities at the level of countries and regions which is where most important 
innovation policy decisions take place. At the level of projects (or collections of projects tackling a 
particular challenge), the gamut of complementarities and potential for improvement is likely greater 
still4. 
Obstacles to complementarities 
However, a number of obstacles can stand in the way of realising such complementarities. The 
inability to plan strategically has been a chief obstacle. The absence of a framework for long-term 
planning in regional (and some cases national) innovation policy has prevented the strategic use of 
funds and of the necessary governance and institutional reforms demanded at various stages of an 
innovation system’s development. The policy idea of Smart Specialisation Strategies (RIS3) has come 
as a response to the need for long-term planning. RIS3 is now helping extend planning horizons and 
unite previously disparate funds and instruments, although much progress remains to be made, 
especially in less developed regions and in countries with little experience in innovation policy. RIS3 
provides an opportunity to harness these complementarities by embedding ESIF and H2020 into the 
region's long-term strategy. But this opportunity is not always recognised and the potential links 
often remain unexploited in a region's strategy and attendant policy interventions. Failing to harness 
these complementarities within the RIS3 process raises the risk of the use of ESIF for innovation in 
ways that do not support meaningful capability accumulation, for instance, by failing to upgrade and 
internationalise public research institutions or by failing to engage with a broad-base of the region’s 
business sector or failing to attenuate territorial imbalances5.  
A key issue appears to be whether there are elements in the design of ESIF and H2020 that prevent 
such complementarities, including mismatches in administrative rules and procedures (see European 
Commission, 2014) and possible lack of adaptation to the economic and institutional realities of 
newer member states. Other important barriers include the absence of national sources of funding 
to develop complementary lines of research and to pick up those parts of the innovation value chain 
not supported by EU funds and, crucially, the absence of a critical mass of R&D-performing 
businesses, necessary if H2020 participation is to have an economic impact in the region. 
                                           
4 See the S2E Joint Statements (http://s3platform.jrc.ec.europa.eu/national-events) and Examples of Synergies 
(http://s3platform.jrc.ec.europa.eu/synergies-examples) for possible project complementarities 
5 Another possible, but not necessarily likely, outcome of the inability to plan strategically is the use of ESIF to 
postpone (if not prevent) the necessary changes by providing a dependable source of financing that 
sustains outmoded modes of governance and institutions (and attendant orientations and functions of 
innovations systems). For example, readily available ESIF funding may be acting as a substitute for H2020 
funding, which in developing regions may remove the incentive to reform and the opportunities to learn 
and improve. 
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Business innovation capabilities as an instrumental development objective 
In a broader sense, identifying exactly how ESIF and H2020 can complement each other, requires an 
understanding of what kind of innovation capabilities are central to productivity and income 
improvements and how they accumulate over time. This understanding can be greatly enhanced by 
studying the developmental paths of what are today advanced innovation systems. The most striking 
feature of advanced innovation systems is the central role of the business sector (Bell, 2009). In 
thriving innovation systems, most R&D is both financed and performed by businesses. Public 
research systems are, of course, central to advancing the frontiers of knowledge and as such are 
necessary pillars of the innovation system, but most economically useful innovation takes place 
within firms. The path to both economic convergence and competitiveness therefore inevitably 
crosses from the accumulation of business innovation capabilities.  
This is why focusing on the smaller subset of policies designed to strengthen business innovation 
capabilities may be a way to enhance the impact of and complementarities between ESIF and H2020. 
Historically, in what are now developed innovation systems, business innovation capabilities are 
accumulated over long periods of time as a function of the systematic carrying out of innovation 
activities internal to firms. These capabilities can be initiated (or "bootstrapped" e.g. with the 
insertion of a first engineer or a first researcher into a company)  where they do not exist, stimulated 
(with innovation vouchers, prizes etc.) and supported in many ways, including by way of targeted 
public investments in human resources, by supporting innovation activities within firms that are 
complementary to R&D (see practical policy directions in Arnold and Thuriaux, 1997; Bell, 2009; 
Cirera et al., 2017) and by way of collaborative research and innovation projects with universities and 
public research organisations (Hanna et al., 1995, p. 80; Arnold and Thuriaux, 1997; Bell, 2009; OECD, 
2014). It would seem therefore that, in addition to national innovation policies, EU investments in 
innovation capacities as supported by ESIF, and in collaborative R&D projects as supported by H2020 
can play an important role in the accumulation of business innovation capabilities.  
Empirical literature suggests that differences in business innovation capabilities lie behind the 
variable outcomes of most measurable dimensions of economically useful innovation: the rate of 
product and process innovation and its economic impact (Frenz and Ietto-Gillier, 2009; Varga et al. 
2014), the extent and quality of university-industry interaction (Azagra-Caro et al., 2013) and even 
the ability of innovation systems to diversify into new sectors (Smith et al., 2005; Bell, 2009). In view 
of this evidence, in the analysis that follows we treat business innovation capabilities not just as an 
instrumental objective of both competitiveness and cohesion policies but also as a defining 
characteristic of regional and national innovation systems in the EU and major differentiator of their 
experiences and needs with respect to both ESIF and H2020. 
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4 Mobilisation of ESIF and H2020 across the EU  
Several aspects related to success in FP/H2020 have been discussed in the previous sections. Many of 
these success factors have so far been primarily described at the level of the research performing 
organisation, but there are also aspects affecting participation that relate to aggregate features of 
the innovation system, at both the national and regional levels.   
In this section we attempt to make sense of structural features of European innovation systems and 
the ways in which they shape FP and ESIF mobilisation. Some of the key features examined include: 
overall R&D investments; the weight of business in the funding and performance of R&D; and the 
internationalisation of research, with its implications for other aspects such as access to networks 
and consortia building. 
Research and innovation funding by source 
Two sets of data were extracted from the JRC R&I regional viewer6: the total of H2020 allocations up 
to July 2017 by NUTS2 region and planned ESIF investments in RTDI relevant categories of 
intervention7. Yearly averages were calculated for each region and were then aggregated to obtain 
the yearly average funding8 at the national level. 
Table 1 provides an overview of R&D expenditures among EU member states, ranked by R&D 
intensity [i.e. Gross domestic expenditure on R&D (GERD) as a percentage of GDP]. With few 
exceptions (most notably Slovenia and the Czech Republic, and to a lesser extent Estonia and 
Hungary), new member states are concentrated towards the bottom of this ranking. The picture is 
not too dissimilar for the Business Enterprise Sector (BES) investments as a proportion of GDP.  
                                           
6 http://s3platform.jrc.ec.europa.eu/synergies-tool 
7 002 - Research and innovation processes in large enterprises; 056 – Investment in infrastructure, capacities 
and equipment in SMEs; 057 – Investment in infrastructure, capacities and equipment in large enterprises; 
058 – Research and innovation infrastructures (public); 059 – Research and innovation infrastructures 
(private, including science parks); 060 -  research and innovation activities in public research centres; 061 
– Research and innovation activities in private research centres; 062 – Technology transfer and university-
enterprise cooperation; 063 – Cluster support and business networks; 064 – Research and innovation 
processes in SMEs (including vouchers); 065 – Research and innovation processes, technology transfer in 
low carbon economy; 066 – Advanced support services for SMEs and groups of SMEs; 067 – SME business 
development, support to entrepreneurship and incubation; 073 – Support to social enterprises (SMEs); 101 
– Cross financing under the ERDF: support to ESF type actions. 
8 The economic indicators for research and innovation investments were extracted from the EUROSTAT website 
(January 2018). The EUROSTAT indicators for research and development (R&D) include statistics on 
expenditure, personnel and government budget allocations for R&D. Data used related to performing sector 
and the source of the funding. Data for the year 2015 were used except where all the data were not 
available, then the next most complete year was used. This is indicated in the tables and charts. By way of 
a caveat, it should be noted that the H2020 funds are actually allocated whereas the ESIF data used are 
only for planned investments. However, data from the 2013 Annual Implementation Report for the period 
2007-2013 show that absorption was generally over 90% (except for developing human potential). While 
there were variations between countries the rate is generally high and should increase as the funds are 
allocated post 2013. This provides some reassurance that planned amounts can be a reasonable estimation 
of investments for the 2014-2020 programming period. 
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Table 1: RTDI investments as a percentage of GDP (2015) 
 
*GDP (2014)  
** GDP (2013) 
***it is not known whether public funding for RTDI as extracted from EUROSTAT would include structural funds or not. It 
depends whether the authority reporting the statistics has the ability to track the funds. However, there is no crossover 
between BES, ESIF and H2020 intensities 
As far as Gross Expenditure on R&D (GERD) by the government and higher education sectors is 
concerned, particularly low levels (below 0.35% of GDP) are evident in six new member states 
(Croatia, Cyprus, Malta, Latvia, Romania, and Bulgaria). ESIF research and innovation related 
investments, however, account for a higher share of GDP in new member states. This is hardly 
surprising for a cohesion instrument meant to facilitate development. However the figures also 
highlight possible mobilisation challenges for ESIF – up to the time covered by our data – particularly 
for Romania.  
By contrast, H2020 tends to account for a higher share of GDP in older member states, which on the 
whole tend to spend more on R&D in general, and more of it is performed by businesses. High R&D 
Country
GERD %  of GDP
(1)
BES %  of GDP
(2)
Public GERD % 
of GDP***
(3)
ESIF % of GDP
(4)
H2020 % of GDP
(5)
Spread between 
H2020 and ESIF 
intensity
(5)-(4)  
SE** 3.310 1.870 0.967 0.018 0.062 0.044
AT 3.050 1.520 1.012 0.012 0.063 0.050
DK 2.960 1.760 0.869 0.010 0.070 0.060
DE 2.920 1.910 0.814 0.022 0.042 0.019
FI 2.900 1.590 0.845 0.034 0.081 0.047
BE 2.470 1.440 0.604 0.015 0.085 0.070
FR* 2.230 1.240 0.794 0.014 0.037 0.023
SI 2.200 1.520 0.444 0.293 0.120 -0.173
NL 2.000 0.970 0.667 0.011 0.088 0.077
CZ 1.930 0.670 0.635 0.257 0.030 -0.228
UK 1.670 0.820 0.486 0.014 0.045 0.031
EE 1.490 0.610 0.693 0.654 0.118 -0.537
HU 1.360 0.680 0.472 0.324 0.045 -0.279
IT 1.340 0.670 0.523 0.042 0.038 -0.004
LU 1.270 0.600 0.627 0.003 0.039 0.035
PT 1.240 0.530 0.605 0.318 0.069 -0.249
ES 1.220 0.560 0.552 0.073 0.065 -0.008
IE 1.200 0.580 0.328 0.010 0.051 0.042
SK 1.180 0.290 0.414 0.362 0.027 -0.335
LT 1.040 0.300 0.383 0.381 0.024 -0.357
PL 1.000 0.390 0.442 0.453 0.016 -0.437
EL 0.970 0.300 0.537 0.111 0.093 -0.019
BG 0.960 0.340 0.196 0.208 0.033 -0.174
HR 0.840 0.390 0.323 0.277 0.028 -0.250
MT 0.770 0.350 0.262 0.121 0.052 -0.069
LV 0.630 0.130 0.218 0.393 0.048 -0.344
RO 0.490 0.180 0.212 0.102 0.017 -0.085
CY 0.480 0.100 0.271 0.062 0.145 0.083
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intensities, to a large extent supported by businesses are the hallmark of dynamic, developed 
innovation systems, thriving on virtuous cycles of innovation investments, synergies between public 
and private R&D activities, higher revenues and productivity improvements due to innovation, and 
further innovation investments. 
As mentioned above, Slovenia, Estonia and the Czech Republic are exceptions among new member 
states. The three countries are among the highest R&I investors, a relatively high share of their 
national research effort is performed by businesses and are also among the biggest ESIF 
beneficiaries. In particular, Estonia stands out as it mobilises a significant amount of ESIF in R&I 
(around one billion for the 2014-2020 period) but is also a good performer in Horizon 2020 based on 
H2020 funding as a percentage of GDP.  
The role of business R&D  
It can be argued that business funding is an appropriate summary indicator of a productive 
innovation system. When business funding flows into public research it is because there is an 
expectation it will lead to economically useful innovation – which on the whole corresponds to public 
research systems which are both well-funded through other sources and rigorously steered and 
governed (OECD, 2005: pp. 16-20; also see OECD, 2011 for recent trends in the governance of public 
research in advanced innovation systems). Like other indicators of business investment, business 
funding of R&D tends to be higher in countries with legal institutions that protect the rights of 
investors and with effective public policy and governance (Guellec and van Pottelsberghe, 2000; 
Brown et al., 2017). On the whole, countries where businesses are willing to fund the bulk of the 
national R&D effort (irrespective of whether performed in-house, or by external R&D services 
suppliers such as universities and PROs) are those who have managed to instigate virtuous cycles 
between resources for innovation, profitable innovation and more resources for innovation. As a 
result they manage to mobilise more resources to innovation overall.  
For these reasons, the share of GERD funded by business can be a revealing indicator of the 
development of a national innovation system. Figure 2 presents the share of different institutional 
funders of R&I (businesses, government, private non-profit and funding from abroad) in the national 
total (GERD), with member states ranked according to the share of business funding. It is 
immediately striking that countries in which businesses finance the bulk of the national R&D effort 
are those with the most dynamic innovation systems (as attested, for example, by the latest 
European Innovation Scoreboard: EIS, 2018), and broadly coincide with those that achieve the 
highest overall R&D intensities too.  
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Figure 2: Sources of RTDI funds in EU – 2015 (*2014, **2013) 
 
 
Where does EU funding fit into this picture? To answer this question additional estimates are 
necessary. Eurostat R&D statistics report funding sourced by the various institutional funders within 
the country and from abroad, including a dedicated category for EU funding "Abroad - European 
Commission" (ABR_EC).  We have further distinguished the broad Eurostat category "Funding from 
Abroad – European Commission" into H2020 and ESIF funding, by multiplying the level of funding 
reported by Eurostat by the share of H2020 and ESIF in the sum total of our administrative-data 
derived indicators. This comes with the caveat that while the distinction between business and public 
funds is clear and certain, we cannot be sure that the same is true of the distinction between 
national and EU funds, the latter of which may on occasion have been (mis)classified as coming from 
national sources9. This suggests that ESIF in particular and likely H2020 may be underrepresented10. 
Presenting ESIF and H2020 in comparison to other sources of R&D funding has the advantage of 
appreciating their relative importance for individual countries, within a framework that is consistent 
with formal R&D statistics. 
                                           
9 According to the Frascati Manual 2015 publicly-financed GERD should contain only national resources (and 
therefore exclude ESIF and H2020 funding). According to EUROSTAT (in a bilateral email exchange on 
15/03/2018), if however, the reporting unit is not capable of tracing the source of funds correctly EU funds 
may be (mis)classified under the national or regional authority. As far as national accounts are concerned, 
according to Eurostat (in a bilateral email exchange on 7/11/2018) ESIF funds would be recorded as a 
transfer from the "Rest of the World". 
10 An ex post verification of the estimated levels of H2020 funding using this method compared to nearest 
available year estimates of levels of H2020 funding available from alternative sources shows that this 
method and the alternatives are within the same order of magnitude (average percentile differences less 
than 50%) and exhibit a high cross-country correlation (Pearson's R=0.9) 
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With respect to EU funding, Figure 2 shows that low shares of business funding correspond to high 
dependence on ESIF. Countries with weaker innovation systems (in terms of both R&D intensity and 
share of business sector in total R&D) tend to be the ones in which the largest proportion of R&D 
funding comes from the EU (including H2020 and ESIF) – new member states in particular but also 
Greece. Only SI goes against this pattern among new member states, and is indeed the country with 
the highest share of BERD in the EU. 
Regional variations 
The national structure of funding provides an important reflection of the national research and 
innovation system. However, there can be significant variation between the different regions in a 
country. These are politically important, especially given the impulse given to the regional dimension 
of innovation policy by RIS3.  
Figures 3 and 4 present H2020 and ESIF intensities for each country respectively, showing the 
national average (as the dot) as well as the maximum and minimum regional intensities 
(corresponding to either extremity of the vertical lines). There are eight smaller countries11 where 
the NUTS2 accounts for the whole country or have been treated as one territory due to their size. 
This constraint confines our examination of sub-national variance to 20 EU member states only.  We 
use mostly the NUTS2 and in some cases NUTS1 level of territorial aggregation (see Methodological 
Notes in section 5 for a fuller explanation). 
Figure 3: H2020 funding intensity showing national average and regional max/min 
 
 
Greece, followed by Spain, Belgium and Italy are the countries with the greatest variations between 
regions in H2020. In the case of ESIF, the largest variations between regions are in Poland, Portugal 
and Hungary. We observe greater differences in regional allocation of funding (defined as the 
                                           
11 Croatia, Cyprus, Estonia, Latvia, Lithuania, Luxembourg, Malta, Slovenia 
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difference between the region with the national minimum and the region with the national 
maximum) for H2020 than for ESIF.  
 
Figure 4: ESIF STI funding intensity showing national average and regional max/min 
 
 
It is also possible to distinguish between capital regions, metropolitan regions and other regions. The 
NUTS3 level is used to identify capital and metropolitan regions, the latter being either a NUTS3 
region on its own right or a combination of NUTS 3 regions which represent all agglomerations of at 
least 250 000 inhabitants12. Of the 20 countries with regional variance, 14 of those with maximum 
H2020 intensity contain capital regions, three have metropolitan regions and three do not contain 
any metropolitan region (EL, IT and SE). For the minimum intensity regions 11 are metropolitan and 
nine are other regions. Capital regions tend to attract more H2020 funding, which underscores the 
importance of co-location for innovation activity of this kind. It also suggests that the magnitude of 
the development challenge for lagging regional innovation systems is proportional to existing 
economic disparities within countries, which should serve to temper expectations about what is 
feasible within politically-relevant timeframes. 
Structure of research and innovation system: international engagement 
The review of determinants for H2020 participation in Section 2 highlighted the role of access to and 
integration into international research networks. International engagement stands to improve the 
innovative performance of a country or region. Furthermore, trans-regional and international 
cooperation is also an important dimension of smart specialisation. New member states have a 
strong dependence on foreign direct investment (FDI) and global value chains and yet their Research 
and Innovation Strategies for Smart Specialisation (RIS3) are not internationalised (Radosevic and 
Stancova, 2015). However, while networks and knowledge flows are considered important for the 
innovation performance of countries and regions (Runiewicz-Wardyn, 2013) it should be 
                                           
12 http://ec.europa.eu/eurostat/web/metropolitan-regions/background 
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remembered that just connecting internationally is not enough: knowledge spillovers may not 
happen in the absence of a minimum necessary level of innovation capabilities in the region 
(Miguélez and Moreno, 2015). 
Figure 5 plots the proportion of internationally co-authored papers13 against the number of 
researchers and engineers in each EU member states (using EUROSTAT data). The horizontal axis 
shows the proportion of international co-publications over the country's total publication output in 
the time period. Figure 5 shows that EU member states tend to follow the well-known pattern of 
smaller countries being engaged in international collaboration more than larger countries (Schubert 
and Braun, 1990; Leclerc and Gagné, 1994). However, it is noticeable that while both old and new 
member states follow this pattern, new member states (in red) as a group are less internationally 
engaged. The lower proportions of international co-authorship are dominated by new member 
states, suggesting that they are not as extensively linked in international research as other EU 
countries. Lack of international connectedness is itself both a cause and an effect of difficulties in 
participating in H202014, but probably goes well beyond it. 
Figure 5: International co-authorship against number of researchers and engineers in a 
country15 
 
Source: Harrap and Doussineau (2017) 
A concerted policy to open up of research and innovation systems in new member states and favour 
internationalisation, should not just support participation in joint research projects, but also include 
                                           
13 This data was extracted from Scopus. The time frame for extracted publications was 2007-2013.  The 
analysis was restricted to articles, conference papers, book chapters and books. International collaboration 
is inferred when the authors' affiliation addresses are in two or more different countries. The co-authorship 
can be attributed to a country (or region) through whole counting where every country with a contributing 
author is counted (Leydesdorff and Wagner, 2008). In fractional counting the country is assigned a fraction 
of the paper. In our case, as our interest is primarily with the presence or absence of an international link 
(rather than the volume of authorship), the whole counting approach is appropriate. 
14 It is indicative that in pairwise correlations between H2020 funding intensity, and a handful of national 
innovation indicators (such as overall R&D intensity, public R&D intensity, business R&D intensity, and co-
publications) the share of international co-publications, followed by business R&D intensity, were the two 
variables with the highest correlation coefficient (0.44 and 0.21 respectively). 
15 Extracted from Scopus and restricted to articles, conference papers, book chapters and books. 
 25 
initiatives catering to the entire chain of knowledge generation and circulation, including training and 
human resource mobility initiatives, the harnessing of diaspora networks, and greater participation in 
international funding consortia.   
 26 
5 H2020 mobilisation relative to ESIF: regional patterns and groupings 
In this section we attempt to characterise EU regions according to their levels of R&D intensity, on 
the one hand and the relative weight of H2020 versus ESIF funding on the other. This mapping can 
highlight some common trends, allowing us to group regions, relate these to possible needs and may 
thus allow policy makers at both the EU and the national levels to better tailor support for innovation 
in those territories. More tailored support to regional authorities would facilitate the identification of 
good practices and their possible transfer between similar regions. 
Regional innovation systems vary enormously and are themselves parts of broader national and 
sectoral innovation systems with distinct trajectories and needs for support. On the basis of prior 
literature that underscores the role of scientific excellence, internationalisation, business innovation 
activity and also complementarities between national funding sources and H2020 participation (see 
section 2), we anticipate that the better a research system is performing on these counts, the more 
funding it can obtain from H2020. Focusing on the specific objective of enhancing the participation of 
regions with weak innovation capabilities in H2020, our attention can be profitably focused on those 
regions where relatively small changes in research and innovation policies can have large impacts. At 
either extremity, there are of course systems with weak innovation capabilities in both the public and 
the business sector and systems with generally strong innovation capabilities, underpinned by 
scientific excellence. Of particular interest here are the various types of other systems in between 
these two extremes. These include systems with relatively strong public research but only moderate 
or weak business innovation capabilities (e.g. EL, PT, and CY) and systems which have managed to 
mobilise considerable resources for research and innovation but have not yet managed to translate 
these into improvements in scientific excellence or economically useful innovation. The latter group 
includes a handful of countries, mostly in Central and Eastern Europe which have relatively recently 
secured large business investments in innovation, primarily as a by-product of FDI, and stand to gain 
the most from further participation in H2020.  
Methodological notes  
Territories taken into account 
In the interest of policy relevance, to the extent that available statistics permit, the territorial level 
assigned corresponds to either the political or the administrative level. In total, the analysis covers 
200 NUTS2 and NUTS1 territorial entities, including country-level “regions” (e.g. CY, MT, LU). This 
reflects the diversity of territorial organisation in the EU and the level of regional policy making in 
each member state16.  
Chosen data and indicators for analysis 
For each region, three types of information help us to position EU regions:  
1. GERD relative to regional GDP. The latest available indicators (2015) are taken from Eurostat. 
2. The total planned amount of ESIF dedicated to Research and innovation at regional level for 
the period 2014-2020. The planned investments in European Structural and Investment 
Funds (ESIF) concerns only funding clearly earmarked for research and innovation, activities. 
                                           
16 Country codes and NUTS level taken into consideration for this analysis: AT=2; BE=1; BG=2; CY=1 (country 
level); CZ=2; DE=1; DK=2;EE=1 (country level); EL=2; ES=2; FI=2; FR=2; HR=1 (country level); HU=2; 
IE=2; LT=1 (country level); LV=1 (country level); MT=1 (country level); NL=1; PL=2; PT=2; RO=2; 
SE=2; SI=1 (country level); SK=2; UK=1 
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Of the funds that make up ESIF17, these are mostly from the European Regional Development 
Fund (ERDF), followed by the European Social Fund (ESF) and the Cohesion Fund in 
decreasing proportions. The territorial level (NUTS level) used depends on the availability of 
data from regional operational programmes (OP) and also the national operational 
programmes. The share of each region in national OPs has been estimated by taking into 
account the population size of the regions and their development stage. Data depicted here 
are thus estimations of planned investments and do not reflect final investment figures. A 
broad definition of research and innovation activities takes into account categories of 
intervention both within and outside the Thematic Objective 1 specifically devoted to them. 
Infrastructures, support to SMEs and social innovation are also considered covering in total 
15 categories of intervention related to Research and innovation (see list in annex 1). 
3. The total amount of Horizon 2020 funding captured by beneficiaries in the regions18. 
 
Chosen thresholds for grouping regions 
Any attempt to group dissimilar entities entails an element of arbitrariness and the present exercise 
is no exception. In terms of regional R&D intensity, a chief consideration for determining a threshold 
is to set it at a level that is indicative of a regional innovation system of intermediate capability. That 
is, an innovation system that has already made some notable progress in mobilising R&D resources, 
including private funds, and therefore stands a reasonable chance of progressing to the more 
systematic, interactive, and ambitious innovation activity that can facilitate meaningful participation 
in H202019. Lacking any other yardstick, and for simplicity's sake, we set the threshold for the level of 
research investment at 1% of GDP. This threshold is far from the EU average of 2.3% (Eurostat, 2015) 
and even further from the Barcelona objective of 3%20. However it is not entirely arbitrary. With only 
a handful of rather uncharacteristic exceptions, the vast majority of regions (about fifty) with H2020-
intensive EU innovation support, spend at least 1% of their GDP on R&D (Figure 1). Additionally, as 
most EU regions cluster around this value, it is not irrelevant or unrealistically beyond reach, as a 
target to aspire to. It therefore seems a fitting threshold for something like a minimum of overall 
R&D activity necessary for the region to stand a reasonable chance of graduating to H2020-intensive 
EU support.  
We also set the reference point for the ratio H2020/ESIF to 1. The level of parity between H2020 and 
ESIF funds has a more straightforward interpretation. If the ratio is inferior to 1, it means the region 
in question is capturing less H2020 funding than it is allocating ESIF, which would be expected in 
                                           
17 There are five European Structural and Investment Funds: European regional development fund (ERDF); 
European social fund (ESF); Cohesion fund (CF); European agricultural fund for rural development 
(EAFRD); and European maritime and fisheries fund (EMFF). 
18 The regionalisation of data  may be affected by a headquarter effect (HQE) in some Member States 
(particularly in France, Italy and Spain) due to the difference between the (physical) location of the actual 
research performer and the (legal) location of the beneficiaries' headquarter (this problem affects in 
particular large public research organisations). Data for France, Italy and Spain have been corrected to 
control for the actual regional location of Horizon 2020 beneficiaries. The period covered by Horizon 2020 
indicators goes from 2014 onwards to June 2017 
19 A single indicator, such as R&D intensity, can of course be only very imperfectly suggestive of the diverse 
and multifaceted research and innovation activity and implied capability. Implicit in its use here is the, not 
entirely unjustified assumption (see, among others, Bell, 2009) that it correlates with a broad swathe of 
complementary innovation investments, activities and capabilities that are strictly not covered by the 
narrow definition of R&D.  
20 The Barcelona European Council’s objective to raise overall R&D investment to 3% of GDP. See 
http://ec.europa.eu/invest-in-research/action/history_en.htm.  
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regions of low innovation capability. If the ratio is above 1, it means the region in question is 
capturing more in H2020 than the funding it allocates through ESIF21, as would be expected of 
regions of higher innovation capability, particularly capital regions and other regions encompassing 
large cities.  
Resulting groups of regions 
Figure 6 plots data for EU regions along two axes:  
 a horizontal axis with R&D intensity, which we take as a summary measure of the overall 
research and innovation effort of each region (in public organisations and in businesses) and; 
 a vertical axis showing the ratio between the amount of Horizon 2020 funding and the 
amount of ESIF funding on R&I by each region (henceforth the H2020-to-ESIF ratio) 22.  
 
It is immediately apparent that there is a moderate correlation between R&D intensity and H2020-
intensive EU support. Regions where R&D accounts for a more significant share of economic activity 
tend to be more successful in attracting H2020 funding, as reflected in the path of the continuous 
regression line. R&D intensity alone explains about 47% of observed differences in the H2020-to-ESIF 
ratio. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                           
21 On R&D intensity dimension (vertical axis),  if x<1 then 'b' else 'a'.  On the ratio H2020/ESIF dimension 
(horizontal axis), if y<1 then 'b' else 'a' 
22 More specifically, the horizontal axis corresponds to regional R&D intensity from Eurostat (2015), i.e.  
 GERD(regio)/GDP(regio) and the vertical axis corresponds to the (log of) the ratio H2020/ESIF: (total 
H2020 funding captured at regional annualised)/(total ESIF allocated to R&I annualised). 
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Figure 6: Three main areas defining EU regions according to R&I spending and their use 
of EU funding  
 
Taking into account the abovementioned thresholds, at least three23 policy-relevant groups of EU 
regions with similar EU fund mobilisation experience for a given R&D intensity can be defined.  
 Group 1: the “Lagging R&I regions” - area defined by low R&D intensity with higher ESIF 
dependence and lower capacities to capture H2020 funding.  
 Group 2: the “Intermediary R&I regions” - area defined by a higher R&I intensity 
combined higher ESIF dependence and lower capacities to capture H2020 funding 
 Group 3: the “Better-performing R&I regions” - area with higher R&D intensity combined 
with lower ESIF dependence.  
Figure 6 points to a notional development path, whereby regions gradually progress from group 1, to 
group 2, through to group 3 as a function of the overall development of their innovation systems – 
loosely proxied here by R&D intensity. Of course actual development paths, and the policies needed 
to support them, are not going to be as straightforward. Yet broad tendencies such as these are 
indicative of the expected progression and relative weights of the two funding streams as a function 
of capability accumulation and are broadly suggestive of the workings of a methodical process of 
cumulative capability accumulation, such as described in Figure 1. 
The number of Lagging and Better-performing R&I regions comprising groups 1 and 3 is 
approximately the same (77 versus 74 regions) but there are other important differences (see Table 2 
below). In terms of population, Better-performing R&I regions are twice as large as the Lagging 
regions, suggesting that urban areas may be more represented in Better-performing regions than in 
                                           
23 The remaining quadrant (a possible Group 4) only gathers 5 atypical regions with a low R&I intensity but with 
good performance in H2020 compared the ESIF planning. However, the small number and diverse 
development and policy trajectories of these regions, preclude a meaningful grouping. 
 30 
other areas. The overall amount of economic activity is an important delineator too. In terms of the 
size of their economies, as measured by GDP, Better-performing regions are about 3 times larger 
than Intermediary regions and 6 times larger than Lagging regions. However, these differences are 
particularly pronounced when considering R&D expenditures. The combined GERD of Better-
performing regions is 4.5 times larger than Intermediary regions and 23 times larger than Lagging 
regions. 
Table 2: Main characteristics of the 4 groupings of regions 
 
Source: Eurostat. Own calculation 
Figure 7 identifies all regions included in the analysis with their NUTS2 codes and Figure 8 places each 
regional grouping on a map. The discussion that follows examines each regional grouping separately. 
Figure 7: EU regions according to their R&D intensity and participation in H2020 and 
planned ESIF allocation 
 
 
Number of 
Regions
% Population (2015) %
GDP (2015) 
Meur
%
Est. GERD 
in Meur
%
Area 1 'Lagging' regions 77 38.5% 118 548 493 23.4% 1 639 158 11.3% 11 152 3.8%
Area 2 'Intermediary' regions 44 22.0% 100 063 078 19.8% 2 091 122 14.4% 31 909 10.8%
Area 3 'Performing' regions 74 37.0% 272 429 984 53.8% 10 093 166 69.3% 245 553 83.0%
Area x regions 5 2.5% 15 120 349 3.0% 742 928 5.1% 7 064 2.4%
Total 200 100.0% 506 161 904 100.0% 14 566 374 100.0% 295 679 100.0%
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Figure 8: Geographical distribution of the identified groups 
 
 
Group 1: Lagging R&I regions: Higher ESIF allocation than H2020 funding and low R&I 
intensity 
This group of regions is the most numerous, comprising 38.5% of the 200 EU28 regions considered 
but represent 23.4% of population, 11.3% of GDP and only 3.8% of R&D expenditure. These regions 
allocate the highest share of ESIF to R&I. At the same time their performance in H2020 is generally 
low. This group is made of mostly new member states (outside of capital regions): PL, CZ, HU, SK, LV, 
and LT. The only exception is Portugal: almost all Portuguese Regions are also in this group. A first 
interpretation could be: Group 1 regions have research and innovation capabilities but are lagging 
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behind in terms of performance in competitive programmes such as Horizon 2020 due to lack of 
broad innovation capabilities and even possible competition between ESIF funding and H2020 (which 
is anecdotally reported in S2E national events but not yet demonstrated). Except Portugal, RIS3 
strategies are designed at the national level and TO1 is managed partially (for Poland) or totally at 
the national level (CZ, HU, SK). As this is a group with many regions, further work may be useful in 
identifying further subgroups, to better discriminate regions and better shape policy directions. 
Table 3: Lagging R&I regions:  Higher ESIF allocation than H2020 funding and low R&I 
intensity 
Group 1 
ESIF allocation > H2020 funding 
R&I intensity <1  
 
77 Regions (38.5%) 
23.4 % of the EU population 
11.3% the EU GDP 
3.8% of EU R&D expenditure 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AT11 Burgenland 
BG31 Severozapaden 
BG32 Severen Tsentralen 
BG33 Severoiztochen 
BG34 Yugoiztochen 
BG42 Yuzhen Tsentralen 
CZ04 Severozapad 
EL11 Anatoliki Makedonia 
EL12 Kentriki Makedonia 
EL13 Dytiki Makedonia 
EL21 Ipeiros 
EL22 Ionia Nisia 
EL23 Dytiki Ellada 
EL24 Sterea Ellada 
EL25 Peloponnisos 
EL41 Voreio Aigaio 
EL42 Notio Aigaio 
ES11 Galicia 
ES12 Principado de Asturias 
ES13 Cantabria 
ES23 La Rioja 
ES42 Castilla-La Mancha 
ES43 Extremadura 
ES53 Islas Baleares 
ES62 Region De Murcia 
ES70 Canarias 
FR21 Champagne-Ardenne 
FR26 Bourgogne 
FR30 Nord - Pas-De-Calais 
FR53 Poitou-Charentes 
FR83 Corse 
HR Hrvatska 
HU22 Nyugat-Dunantul 
HU23 Del-Dunantul 
HU31 Eszak-Magyarorszag 
ITC2 Valle dAosta 
ITF1 Abruzzo 
ITF2 Molise 
ITF4 Puglia 
 
ITF5 Basilicata 
ITF6 Calabria 
ITG1 Sicilia 
ITG2 Sardegna 
ITI2 Umbria 
ITI3 Marche 
LT Lietuva 
LV Latvija 
MT Malta 
PL11 Lodzkie 
PL22 Slaskie 
PL31 Lubelskie 
PL33 Swietokrzyskie 
PL34 Podlaskie 
PL41 Wielkopolskie 
PL42 Zachodniopomorskie 
PL43 Lubuskie 
PL51 Dolnoslaskie 
PL52 Opolskie 
PL61 Kujawsko-Pomorskie 
PL62 Warminsko-Mazurskie 
PL63 Pomorskie 
PT15 Algarve 
PT18 Alentejo 
PT20 Acores 
PT30 Madeira 
RO11 Nord-Vest 
RO12 Centru 
RO21 Nord-Est 
RO22 Sud-Est 
RO31 Sud - Muntenia 
RO32 Bucuresti – Ilfov 
RO41 Sud-Vest Oltenia 
RO42 Vest 
SE32 Mellersta Norrland 
SK02 Zapadne Slovensko 
SK03 Stredne Slovensko 
SK04 Vychodne Slovensko 
Group 2: 'Intermediary' R&I regions:  Higher ESIF allocation than H2020 funding and higher 
R&I intensity 
This intermediate group can be considered as a 'transition' stage between groups 1 and 3. Assuming 
that regional innovation systems in this group can continue on a sustainable development trajectory, 
progressively more R&D–intensive, more interactive and more ambitious innovation activity would 
reduce the dependence on ESIF funding and reinforce capacity of research organisations (public and 
private) to secure Horizon 2020 funding.  
As these regions are positioned away from the central tendency of EU regions (denoted by the 
continuous regression line in Figures 1 and 2), it can be argued that their H2020 performance is 
below what would be expected in view of their R&D intensity. The challenge for these regions is to 
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identify the necessary bottlenecks, both in the orientation/governance of their public research and in 
terms of capability accumulation in the business sector so that they reap the benefits of the already 
notable local R&D activity. As this group of regions is also numerous, creating further subgroups 
could be useful. For instance, South Moravia (CZ06) is among the EU regions with the highest R&D 
intensity but with only a low ratio of H2020/ESIF, and is likely to require different policy interventions 
than other members of this group.    
Table 4: Intermediary R&DI regions: Higher ESIF allocation than H2020 funding and 
higher R&I intensity 
Group 2  
ESIF allocation > H2020 funding  
R&I intensity>1  
 
44 Regions (22%) 
19.8% of the EU population 
14.4% the EU GDP 
10.8% of EU R&D expenditure 
 
BG41 Yugozapaden 
CZ02 Stredni Cechy 
CZ03 Jihozapad 
CZ05 Severovychod 
CZ06 Jihovychod 
CZ07 Stredni Morava 
CZ08 Moravskoslezsko 
DE4 Brandenburg 
DE8 Mecklenburg-Vorpomn 
DED Sachsen 
DEE Sachsen-Anhalt 
DEF Schleswig-Holstein 
DEG Thuringen 
DK02 Sjaelland 
EE Eesti 
EL14 Thessalia 
ES41 Castilla Y Leon 
ES52 Comunidad Valenciana 
ES61 Andalucia 
FR22 Picardie 
FR23 Haute-Normandie 
FR24 Centre 
 
FR25 Basse-Normandie 
FR41 Lorraine 
FR43 Franche-Comte 
FR51 Pays De La Loire 
FR61 Aquitaine 
FR63 Limousin 
FR72 Auvergne 
HU21 Kozep-Dunantul 
HU32 Eszak-Alfold 
HU33 Del-Alfold 
ITF3 Campania 
PL12 Mazowieckie 
PL21 Malopolskie 
PL32 Podkarpackie 
PT11 Norte 
PT16 Centro 
SE21 Smaland och oarna 
SE31 Norra Mellansverige 
SI Slovenija 
SK01 Bratislavsky Kraj 
UKL Wales 
UKN Northern Ireland 
 
Group 3: Better-performing R&I regions:  Higher H2020 funding than ESIF allocation and 
higher R&I intensity 
Group 3 could be considered as the target to reach for all other EU28 regions. This group gathers the 
regions with the highest R&D intensity and is mostly composed of regions from western EU (EU 15) 
and capital regions from new Member States.  
Agglomeration in a region and the presence of large companies in particular, may influence 
considerably the level of R&D expenditure. Among the regions with the highest EU R&D intensity 
figure regions with important corporate presences, for instance by Airbus for the Midi-Pyrenees 
NUTS2 (FR62) region (now part of the new Occitanie region) in France.  The Styria region (AT22) in 
Austria and Baden-Württemberg region (DE1) in Germany are also among the biggest R&D investors 
in the EU. Subgroups may better discriminate regions in this group too: as our chosen R&D intensity 
threshold is low (1%) there is ample room to discriminate regions between 1% and regions with the 
highest R&D intensity (near 5%).  
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Table 5: Better-performing R&I regions: Higher H2020 funding than ESIF allocation and 
higher R&I intensity 
 
Group 3 
H2020 funding capture >  ESIF allocation  
R&I intensity >1  
  
74 Regions (37%) 
53.8 % of the EU population 
69.3% the EU GDP 
83% of EU R&D expenditure 
 
 
AT12 Niederosterreich 
AT13 Wien 
AT21 Karnten 
AT22 Steiermark 
AT31 Oberosterreich 
AT32 Salzburg 
AT33 Tirol 
AT34 Vorarlberg 
BE1 Region De Bruxelles-  
BE2 Vlaams Gewest 
BE3 Region Wallonne 
CZ01 Praha 
DE1 Baden-Wurttemberg 
DE2 Bayern 
DE3 Berlin 
DE5 Bremen 
DE6 Hamburg 
DE7 Hessen 
DE9 Niedersachsen 
DEA Nordrhein-
Westfalen 
DEB Rheinland-Pfalz 
DEC Saarland 
DK01 Hovedstaden 
DK03 Syddanmark 
DK04 Midtjylland 
DK05 Nordjylland 
EL43 Kriti 
ES21 Pais Vasco 
ES22 Navarra 
ES30 Comunidad De 
Madrid 
ES51 Cataluna 
FI19 Lansi-Suomi 
FI1B Helsinki-Uusimaa 
FI1C Etela-Suomi 
FI1D Pohjois- Ja Ita-Suomi 
FR10 Ile De France 
FR42 Alsace 
 
FR52 Bretagne 
FR62 Midi-Pyrenees 
FR71 Rhone-Alpes 
FR81 Languedoc-Roussillon 
FR82 Prov-Alpes-Côte Dazur 
HU10 Kozep-Magyarorszag 
IE01 Border Midland And W 
IE02 Southern and Eastern 
ITC1 Piemonte 
ITC3 Liguria 
ITC4 Lombardia 
ITH2 Trento 
ITH3 Veneto 
ITH4 Friuli-Venezia Giulia 
ITH5 Emilia-Romagna 
ITI1 Toscana 
ITI4 Lazio 
LU Luxembourg 
NL1 Noord-Nederland 
NL2 Oost-Nederland 
NL3 West-Nederland 
NL4 Zuid-Nederland 
PT17 Lisboa 
SE11 Stockholm 
SE12 Östra Mellansverige 
SE22 Sydsverige 
SE23 Vastsverige 
SE33 Övre Norrland 
UKC North East (England) 
UKD North West (England) 
UKE Yorksh and The Humber 
UKF East Midlands (England) 
UKG West Midlands (England) 
UKH East Of England 
UKJ South East (England) 
UKK South West (England) 
UKM Scotland 
 
35 
6 Concluding remarks: creating virtuous cycles of European funding, 
research excellence and economically useful innovation 
Targeting ESIF support towards strengthening scientific excellence, by investing in, upgrading and 
reorienting regional and national research systems so that they are increasingly internationalised, 
appears a meaningful policy direction. ESIF support for capability development of this kind and 
associated governance reforms – e.g. in terms of recruitment, mobility, collaboration and evaluation 
practices - can progressively anchor research teams, institutions, and entire innovation systems into 
science and technology networks dealing with research questions of global significance. Insofar as 
international scientific collaboration is a precursor to H2020 participation, it should also help raise 
the participation of these regions in H2020, instigating a virtuous cycle of capability accumulation 
and scientific excellence.  
The evidence presented in this report highlights that there are large gaps of both capabilities and 
outcomes between and across EU member states and their constituent regions. Mobilising EU 
funding for research and innovation in the countries and regions that stand to gain the most from 
them is a formidable challenge, requiring a context-specific understanding of the bottlenecks and 
tailored solutions. However, the stylised development path discussed in this report foresees both a 
division of labour and synergies between ESIF and H2020, and holds the following policy lessons for 
all developing regions: 
 Whereas ESIF is geared towards strengthening innovation capabilities of all kinds, H2020
is very much focused on research problems of global economic significance. For new
member states in particular, improving participation in H2020 is more than just about
access to funding – it is about setting the basis for a public research system that operates
at the global level.
 Lack of sufficient international orientation and connectedness is likely both a cause and
an effect of the difficulties new member states face in participating in H2020. In this
context, the opening up and internationalisation of research and innovation systems can
be a profitable instrumental objective for innovation policy in general and RIS3 in
particular.
 Disparity in business innovation capabilities, particularly between new and old member
states, also appears to be a delineator of H2020 mobilisation. Strengthening the
innovation capabilities of businesses can be a complementary instrumental objective for
ESIF that would have many other obvious benefits besides H2020 mobilisation.
 National funding is also important. Success in the mobilisation of EU instruments also
depends on complementary policy interventions at the national level. Regional
innovation ecosystems are themselves part of national, and technological/sectoral
innovation systems that cannot always be supported by EU funds.
 The synergies at the level of policies we highlight here – such as the conditionality of
H2020 success on ESIF support for scientific excellence and of support for business
innovation capabilities - are especially important for RIS3, as they imply that finely
tailored territorial strategies employing a sophisticated and appropriate sequenced
policy mix can be profitable.
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Further analytical work can provide more specific directions for policy development. For instance, 
matching the regional data already examined with the specialisation areas available on the JRC's 
Eye@RIS3 database24 or other economic indicators (unemployment rate, research capacity such as 
number of researchers etc.), similarities between regions within a group can be further investigated. 
A thematic approach can be envisaged by selecting areas in H2020 and considering only regions that 
have chosen the same area of specialisation in their RIS3. Boundaries can be refined or adapted in 
order to investigate more precisely regional characteristics. For example, Group 3 and 4 can each 
potentially be divided further into two sub-groups according to H2020 performance. The incidence 
and conditions under which (the anecdotally reported but not yet confirmed) discretionary 
substitution between ESIF and H2020 can occur should be investigated further. 
 
  
                                           
24 Innovation Priorities in Europe - http://s3platform.jrc.ec.europa.eu/map.  
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Annex 
Annex List of categories of intervention taken into account to define R&I in ESIF 
002 Research and innovation processes in large enterprises-  
056 Investment in infrastructure in SMEs-  
057 Investment in infrastructure capacities and equipment in large enterprises- 
058 Research and innovation infrastructures (public)-  
059 Research and innovation infrastructures (private incl. science parks)-  
060 Research and innovation activities in public research centre)- 
061 Research and innovation activities in private research centre- 
062 Technology transfer and university-enterprise cooperation- 
063 Cluster support and business networks- 
064 Research and innovation processes in SMEs (including voucher)- 
065 Research & innovation processes, Techno transfer in low carbon economy- 
066 Advanced support services for SMEs and groups of SMEs-  
067 SME business development support to entrepreneurship and incubation- 
073 Support to social enterprises (SMEs)- 
101 Cross financing under the ERDF: support to ESF type actions 
GETTING IN TOUCH WITH THE EU 
In person 
All over the European Union there are hundreds of Europe Direct information centres. You can find the 
address of the centre nearest you at: http://europea.eu/contact 
On the phone or by email 
Europe Direct is a service that answers your questions about the European Union. You can contact this 
service: 
- by freephone: 00 800 6 7 8 9 10 11 (certain operators may charge for these calls), 
- at the following standard number: +32 22999696, or 
- by electronic mail via: http://europa.eu/contact 
FINDING INFORMATION ABOUT THE EU 
Online 
Information about the European Union in all the official languages of the EU is available on the Europa 
website at: http://europa.eu 
EU publications 
You can download or order free and priced EU publications from EU Bookshop at: 
http://bookshop.europa.eu. Multiple copies of free publications may be obtained by contacting Europe 
Direct or your local information centre (see http://europa.eu/contact). 
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